Related Experiment Video
Updated: Mar 15, 2026
06:58
Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
7.9K
Mood disorders in the elderly: prevalence, functional impact, and management challenges
Leandro da Costa Lane Valiengo1, Florindo Stella2, Orestes Vicente Forlenza1
1Laboratory of Neuroscience (LIM-27), Department and Institute of Psychiatry, Faculty of Medicine, University of São Paulo, Sao Paulo.
Neuropsychiatric Disease and Treatment
|September 8, 2016
Summary
Late-life depression and bipolar disorder (BD) carry higher risks for older adults, including medical issues, cognitive decline, and mortality. Research is growing, but more controlled studies are needed for effective management.
Area of Science:
- Geriatric psychiatry
- Neuroscience
- Clinical psychology
Background:
- Late-life depression and bipolar disorder (BD) are associated with significant negative outcomes, including medical comorbidities, cognitive deficits, and increased mortality.
- While less prevalent than in younger adults, these mood disorders in the elderly present unique challenges.
Purpose of the Study:
- To review current research on the prevalence, clinical presentation, and cognitive/functional impact of mood disorders in the elderly.
- To discuss the neurobiological underpinnings and treatment specificities for late-life depression and BD.
- To explore the implications of these findings for managing mood disorders in older adults.
Main Methods:
- Review of clinical-epidemiological studies focusing on mood disorders in the elderly.
- Analysis of existing literature on prevalence, clinical presentation, and cognitive/functional impact.
- Synthesis of data on neurobiological factors and treatment approaches.
Main Results:
- Mood disorders in the elderly are linked to higher rates of medical comorbidities, cognitive impairment, and mortality.
- Scientific interest in late-life BD and geriatric depression has increased, yet controlled data remain limited.
- Existing studies highlight the multifactorial nature of these associations, involving biological and psychosocial factors.
Conclusions:
- Effective management of mood disorders in older adults requires a comprehensive understanding of their unique presentation and associated risks.
- Further controlled research is crucial to elucidate neurobiological mechanisms and refine treatment strategies for geriatric depression and BD.
- Addressing medical comorbidities and cognitive deficits is essential for improving outcomes in elderly patients with mood disorders.
More Related Videos
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
340
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
340
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
308
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
308
01:27Depressive Disorders: MDD and Dysthymia
1.0K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.0K
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
298
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
298
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
316
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
316
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
305
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
305